SC 13D Filing

Company

AIM ImmunoTech Inc.

Filed

April 9, 2019

Accession Number

0001493152-19-005045

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →